Protective effects of dietary L-arginine supplementation on chronic cyclosporine nephrotoxicity

Transplantation

Volumn 64, Issue 9, 1997, Pages 1236-1240

  Andoh, Takeshi F ^a,b   Gardner, Michael P ^a   Bennett, William M ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; DIET SUPPLEMENTATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SYNTHESIS; FIBROSING ALVEOLITIS; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; KIDNEY FUNCTION; LONG TERM CARE; MALE; NEPHROTOXICITY; NONHUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; RAT; VASOCONSTRICTION;

ANIMALS; ARGININE; BLOOD PRESSURE; CYCLOSPORINE; ENZYME INHIBITORS; FIBROSIS; GLOMERULAR FILTRATION RATE; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY DISEASES; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY; VASCULAR DISEASES;

EID: 0030666719     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199711150-00002     Document Type: Article

References (24)

1. Bennett WM, Demattos A, Meyer MM, Andoh T, Barry JM. Chronic cyclosporine nephropathy: the Achilles heel of immunosuppressive therapy. Kidney Int 1996; 50: 1089.
2. Myers BD, Sibley R, Newton L, et al. The long-term course of cyclosporine-associated chronic nephropathy. Kidney Int 1988; 33: 590.
3. Andoh TF, Lindsley J, Franceschini N, Bennett WM. Synergistic effects of cyclosporine and rapamycin in a chronic nephrotoxicity model. Transplantation 1996; 62: 311.
4. Burdmann EA, Andoh TF, Rosen S, et al. Experimental nephrotoxicity, hepatotoxicity and pharmacokinetics of cyclosporin G versus cyclosporin A. Kidney Int 1994; 45: 684.
5. Conger JD, Kim GE, Robinette JB. Effects of Ang II, ETA, and TxA2 receptor antagonists on cyclosporin A renal vasoconstriction. Am J Physiol 1994; 267: F443.
6. Amore A, Gianoglio B, Ghigo D, et al. A possible role for nitric oxide in modulating the functional cyclosporine toxicity by arginine. Kidney Int 1995; 47: 1507.
7. Gaston RS, Schlessinger SD, Sanders PW, Barker CV, Curtis JJ, Warnock DG. Cyclosporine inhibits the renal response to L-arginine in human kidney transplant recipients. J Am Soc Nephrol 1995; 5: 1426.
8. Bobadilla NA, Tapia E, Franco M, et al. Role of nitric oxide in renal hemodynamic abnormalities of cyclosporin nephrotoxicity. Kidney Int 1994; 46: 773.
9. 2+. Circ Res 1994; 74: 477.
10. De Nicola L, Thomson SC, Wead LM, Brown MR, Gabbai FB. Arginine feeding modifies cyclosporine nephrotoxicity in rats. J Clin Invest 1993; 92: 1859.
11. Gallego MJ, Lopez Farre A, Riesco A, et al. Blockade of endothelium-dependent responses in conscious rats by cyclosporin A: effect of L-arginine. Am J Physiol 1993; 264: H708.
12. Vigano E, Badalamenti S, Paone G, et al. Renal effects of L-arginine infusion in cyclosporine-treated transplant recipients. Transplant Proc 1994; 26: 2622.
13. Akita K, Dusting GJ, Hickey H. Suppression of nitric oxide production by cyclosporin A and FK506A in rat vascular smooth muscle cells. Clin Exp Pharmacol Physiol 1994; 21: 231.
14. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329: 2002.
15. Ujiie K, Yuen J, Hogarth L, Danziger R, Star RA. Localization and regulation of endothelial NO synthase mRNA expression in rat kidney. Am J Physiol 1994; 267: F296.
16. Gardner MP, Houghton DC, Andoh TF, Lindsley J, Bennett WM. Clinically relevant doses and blood levels produce experimental cyclosporine nephrotoxicity when combined with nitric oxide inhibition. Transplantation 1996; 61: 1506.
17. Andoh TF, Burdmann EA, Fransechini N, Houghton DC, Bennett WM. Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506. Kidney Int 1996; 50: 1110.
18. Young BA, Burdmann EA, Johnson RJ, et al. Cyclosporine A induced arteriolopathy in a rat model of chronic cyclosporine nephropathy. Kidney Int 1995; 48: 431.
19. Conde M, Andrade J, Bedoya FJ, Santa Maria C, Sobrino F. Inhibitory effect of cyclosporin A and FK506 on nitric oxide production by cultured macrophages: evidence of a direct effect on nitric oxide synthase activity. Immunology 1995; 84: 476.
20. Mundel P, Bachmann S, Bader M, et al. Expression of nitric oxide synthase in kidney macula densa cells. Kidney Int 1992; 42: 1017.
21. Wilcox CS, Welch WJ, Murad F, et al. Nitric oxide synthase in macula densa regulates glomerular capillary pressure. Proc Natl Acad Sci USA 1992; 89: 11993.
22. Ito S, Arima S, Ren YL, Juncos LA, Carretero OA. Endotheliumderived relaxing factor/nitric oxide modulates angiotensin II action in the isolated microperfused rabbit afferent but not efferent arteriole. J Clin Invest 1993; 91: 2012.
23. De Nicola L, Blantz RC, Gabbai FB. Nitric oxide and angiotensin II: glomerular and tubular interaction in the rat. J Clin Invest 1992; 89: 1248.
24. Fichier RH, Franceschini N, Young BA, et al. Pathogenesis of cyclosporine nephropathy: roles of angiotensin II and osteopontin. J Am Soc Nephrol 1995; 6: 1186.